BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25129342)

  • 21. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
    Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
    Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
    Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
    Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.
    Coward WR; Watts K; Feghali-Bostwick CA; Jenkins G; Pang L
    Mol Cell Biol; 2010 Jun; 30(12):2874-86. PubMed ID: 20404089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
    Caslini C; Hong S; Ban YJ; Chen XS; Ince TA
    Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
    Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
    Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen.
    Jang ER; Lim SJ; Lee ES; Jeong G; Kim TY; Bang YJ; Lee JS
    Oncogene; 2004 Mar; 23(9):1724-36. PubMed ID: 14676837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel MAPK-microRNA signature is predictive of hormone-therapy resistance and poor outcome in ER-positive breast cancer.
    Miller PC; Clarke J; Koru-Sengul T; Brinkman J; El-Ashry D
    Clin Cancer Res; 2015 Jan; 21(2):373-85. PubMed ID: 25370469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines.
    Contreras-Leal E; Hernández-Oliveras A; Flores-Peredo L; Zarain-Herzberg Á; Santiago-García J
    Mol Carcinog; 2016 Oct; 55(10):1477-85. PubMed ID: 26331238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition.
    Siddiqui H; Solomon DA; Gunawardena RW; Wang Y; Knudsen ES
    Mol Cell Biol; 2003 Nov; 23(21):7719-31. PubMed ID: 14560017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
    Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
    Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms.
    Izquierdo-Torres E; Hernández-Oliveras A; Meneses-Morales I; Rodríguez G; Fuentes-García G; Zarain-Herzberg Á
    Int J Biochem Cell Biol; 2019 Aug; 113():37-47. PubMed ID: 31173924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer.
    Yan L; Yang X; Davidson NE
    J Mammary Gland Biol Neoplasia; 2001 Apr; 6(2):183-92. PubMed ID: 11501578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
    Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE
    Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line.
    Varshochi R; Halim F; Sunters A; Alao JP; Madureira PA; Hart SM; Ali S; Vigushin DM; Coombes RC; Lam EW
    J Biol Chem; 2005 Feb; 280(5):3185-96. PubMed ID: 15557281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.
    Liu Y; Hong Y; Zhao Y; Ismail TM; Wong Y; Eu KW
    Cancer Invest; 2008 Jul; 26(6):575-82. PubMed ID: 18584348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors.
    Puppin C; D'Aurizio F; D'Elia AV; Cesaratto L; Tell G; Russo D; Filetti S; Ferretti E; Tosi E; Mattei T; Pianta A; Pellizzari L; Damante G
    Endocrinology; 2005 Sep; 146(9):3967-74. PubMed ID: 15919754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.